Copyright © 2012 Monica Gaidhane et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Backgrounds. Limited effective palliative treatments exist for pancreatic cancer which includes surgery or chemotherapy. Radiofrequency ablation (RFA) uses high frequency alternating current to ablate diseased tissue and has been used to treat various tumors. In this study, we evaluated a prototype probe adjusted to the EUS-needle to perform EUS-RFA to permit coagulative necrosis in the pancreas. Methods. Five Yucatan pigs underwent EUS-guided radiofrequency ablation of the head of their pa...
Currently, the standard treatment for pancreatic neoplasms is surgical resection. However, pancreati...
Radiofrequency ablation (RFA) has been regarded as an established technique to treat various disease...
BackgroundPreclinical testing of new locoregional therapies for pancreatic cancer has been challengi...
Radiofrequency ablation is a possible palliative treatment for patients suffering from pancreatic ne...
Objectives: The use of thermal ablative therapies in the pancreatic tumors is limited because of the...
The original publication is available at www.springerlink.comBackground: Pancreatic cancer has a dis...
International audiencePancreatic adenocarcinoma is one of the most aggressive cancer. Regardless of ...
Objective: To investigate the feasibility and safety of high intensity focused ultrasound (HIFU) tre...
[EN] Radiofrequency energy has been used both experimentally and clinically to manage the pancreatic...
Context The development of linear array therapeutic probes with a large working channel (3.8 mm) has...
BACKGROUND: Irreversible electroporation (IRE) with needle electrodes is being explored as treatment...
Purpose Pancreatic cancer is typically diagnosed in a late stage with limited therapeutic options. F...
Irreversible electroporation (IRE) with needle electrodes is being explored as treatment option in l...
AbstractBackgroundIrreversible electroporation (IRE) is a novel, non-thermal method of tissue ablati...
© KargerBackgroundPalliation of pancreatic cancer remains the only option for the majority of patien...
Currently, the standard treatment for pancreatic neoplasms is surgical resection. However, pancreati...
Radiofrequency ablation (RFA) has been regarded as an established technique to treat various disease...
BackgroundPreclinical testing of new locoregional therapies for pancreatic cancer has been challengi...
Radiofrequency ablation is a possible palliative treatment for patients suffering from pancreatic ne...
Objectives: The use of thermal ablative therapies in the pancreatic tumors is limited because of the...
The original publication is available at www.springerlink.comBackground: Pancreatic cancer has a dis...
International audiencePancreatic adenocarcinoma is one of the most aggressive cancer. Regardless of ...
Objective: To investigate the feasibility and safety of high intensity focused ultrasound (HIFU) tre...
[EN] Radiofrequency energy has been used both experimentally and clinically to manage the pancreatic...
Context The development of linear array therapeutic probes with a large working channel (3.8 mm) has...
BACKGROUND: Irreversible electroporation (IRE) with needle electrodes is being explored as treatment...
Purpose Pancreatic cancer is typically diagnosed in a late stage with limited therapeutic options. F...
Irreversible electroporation (IRE) with needle electrodes is being explored as treatment option in l...
AbstractBackgroundIrreversible electroporation (IRE) is a novel, non-thermal method of tissue ablati...
© KargerBackgroundPalliation of pancreatic cancer remains the only option for the majority of patien...
Currently, the standard treatment for pancreatic neoplasms is surgical resection. However, pancreati...
Radiofrequency ablation (RFA) has been regarded as an established technique to treat various disease...
BackgroundPreclinical testing of new locoregional therapies for pancreatic cancer has been challengi...